AMP Alternative Medical Products (AMP) and Eurox Pharma have begun the sales of Dronabinol produced in Germany by Eurox.
Greenrise Global subsidiary, AMP and Eurox, a SEED Innovations Limited portfolio company and one of Europe’s leading medical cannabis companies, entered into a non-exclusive marketing and distribution agreement for Dronabinol for sale in pharmacies to begin in February 2022.
In preparation for sales, AMP has trained its national sales team on the benefits of Dronabinol – a pure THC product primarily used in pain therapy – for patients to doctors and preparation methods for pharmacists.
Chairman of Eurox, Neil Smith, commented: “If you’re a believer in the ‘Made in Germany’, then that means Eurox.
“AMP’s focus on serving German patients and its national sales coverage make them a perfect partner for us.”
Eurox was one of the first medical cannabis companies to produce Dronabinol made in Germany at one of Europe’s largest GMP facilities located in Hessen, Germany.
The company controls the entire supply chain from cultivation, production to distribution ensuring a stable and efficient supply to its customers.
AMP is based in Erfurt and supplies medical cannabis products to pharmacies across Germany, including medical cannabis brands from Aphria, Bedrocan, Little Green Pharma and AMP’s branded line of products.
Eurox began the white label sale of its dronabinol products to a number of select customers in November 2021. Eurox selected Materia Deutschland, a wholly-owned subsidiary of European medical cannabis and CBD wellness products Materia, as as a distribution partner for its medical cannabis extracts.
[activecampaign form=31]
